aibioVaccinex files Form 25 to voluntarily withdraw its stock from Nasdaq
Tickers VCNX
The Rochester, New York company filed the notice on March 17, 2025. It covers its common stock, par value $0.0001 per share.
Key facts
- Company
- Vaccinex, Inc. (OTC: VCNX)
- News type
- Listings
- Primary source
- Vaccinex, Inc. 25 (2025-03-17)
Vaccinex, Inc. has filed a Form 25 with the Securities and Exchange Commission to remove its common stock from listing on The Nasdaq Stock Market LLC. The notice is dated March 17, 2025.
A Form 25 is the document that ends a security's listing and registration on a national exchange.
In this case Vaccinex checked the box for 17 CFR 240.12d2-2(c), the provision for a voluntary withdrawal by the issuer. The filing states that the company "has complied with the rules of the Exchange" and the requirements of that rule governing the voluntary withdrawal of the class of securities from listing and registration on the exchange. The box for a removal initiated by the exchange under 17 CFR 240.12d2-2(b) was left unchecked.
The class of securities covered is the company's common stock, par value $0.0001 per share. The filing lists the company's principal executive offices at 1895 Mount Hope Avenue in Rochester, New York, and its Commission File Number as 001-38624.
The full notice is available on the SEC website.